AKUMIN INC (AKU) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:AKU • US01021X1000

0.2887 USD
-0.06 (-17.87%)
At close: Oct 25, 2023
0.2875 USD
0 (-0.42%)
After Hours: 10/25/2023, 8:00:00 PM

AKU Key Statistics, Chart & Performance

Key Statistics
Market Cap25.84M
Revenue(TTM)750.96M
Net Income(TTM)-161.10M
Shares89.52M
Float55.08M
52 Week High1.79
52 Week Low0.12
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.8
PEN/A
Fwd PEN/A
Earnings (Next)11-07
IPO2017-12-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
AKU short term performance overview.The bars show the price performance of AKU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 -50 100

AKU long term performance overview.The bars show the price performance of AKU in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AKU is 0.2887 USD. In the past month the price increased by 88.69%. In the past year, price decreased by -83.87%.

AKUMIN INC / AKU Daily stock chart

AKU Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to AKU. When comparing the yearly performance of all stocks, AKU is a bad performer in the overall market: 80.71% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AKU Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AKU. AKU has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKU Financial Highlights

Over the last trailing twelve months AKU reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -118.41% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -9.35%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-13.13%
Sales Q2Q%0.71%
EPS 1Y (TTM)-118.41%
Revenue 1Y (TTM)38.2%

AKU Forecast & Estimates

8 analysts have analysed AKU and the average price target is 0.92 USD. This implies a price increase of 217.98% is expected in the next year compared to the current price of 0.2887.

For the next year, analysts expect an EPS growth of 45.08% and a revenue growth 3.13% for AKU


Analysts
Analysts45
Price Target0.92 (218.67%)
EPS Next Y45.08%
Revenue Next Year3.13%

AKU Ownership

Ownership
Inst Owners0%
Ins Owners15.75%
Short Float %N/A
Short RatioN/A

AKU Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.5495.512B
CI THE CIGNA GROUP9.0872.582B
LH LABCORP HOLDINGS INC15.4422.894B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2793.9822.748B
DGX QUEST DIAGNOSTICS INC18.3321.05B
GH GUARDANT HEALTH INC N/A13.676B
DVA DAVITA INC11.2810.029B
BTSG BRIGHTSPRING HEALTH SERVICES28.066.723B
CHE CHEMED CORP17.626.284B
HIMS HIMS & HERS HEALTH INC40.155.555B

About AKU

Company Profile

AKU logo image Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. The company is headquartered in Plantation, Florida and currently employs 3,859 full-time employees. The company went IPO on 2017-12-01. The firm provides imaging procedures, which include magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. The firm through a network of approximately 200 owned and/or operated imaging locations, outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across over 46 states. Its center locations include Delaware, Florida North, Florida Central, Florida South, Florida West, Illinois, Kansas, Massachusetts, Pennsylvania North, Pennsylvania South, Texas Dallas-Fort Worth, Texas El Paso, Texas North and Texas South. Its subsidiaries include Advanced Diagnostic Group, LLC, Advanced Diagnostic Resources, LLC and Affiliated PET Systems, LLC.

Company Info

AKUMIN INC

8300 W Sunrise Blvd

Plantation FLORIDA US

Employees: 3859

AKU Company Website

Phone: 19546784489.0

AKUMIN INC / AKU FAQ

Can you describe the business of AKUMIN INC?

Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. The company is headquartered in Plantation, Florida and currently employs 3,859 full-time employees. The company went IPO on 2017-12-01. The firm provides imaging procedures, which include magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. The firm through a network of approximately 200 owned and/or operated imaging locations, outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across over 46 states. Its center locations include Delaware, Florida North, Florida Central, Florida South, Florida West, Illinois, Kansas, Massachusetts, Pennsylvania North, Pennsylvania South, Texas Dallas-Fort Worth, Texas El Paso, Texas North and Texas South. Its subsidiaries include Advanced Diagnostic Group, LLC, Advanced Diagnostic Resources, LLC and Affiliated PET Systems, LLC.


What is the current price of AKU stock?

The current stock price of AKU is 0.2887 USD. The price decreased by -17.87% in the last trading session.


Does AKUMIN INC pay dividends?

AKU does not pay a dividend.


How is the ChartMill rating for AKUMIN INC?

AKU has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is AKUMIN INC (AKU) stock traded?

AKU stock is listed on the Nasdaq exchange.


What is the expected growth for AKU stock?

The Revenue of AKUMIN INC (AKU) is expected to grow by 3.13% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.